DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Q3 2022 13F-HR Holdings
Net value change ($000)
+175,359
(3.6%)
New positions
16
Sold out positions
10
Turnover %
20.7%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| NUVL | 113,726 | 43.4% |
| BIIB | 88,110 | NEW |
| CPRX | 62,816 | NEW |
| CareMax, Inc. | 54,879 | 95.3% |
| LRMR | 42,785 | 374.4% |
| RVMD | 39,645 | 228.1% |
| AERIE PHARMACEUTICALS INC | 38,243 | 108.6% |
| PHAT | 26,757 | NEW |
| IDYA | 26,015 | NEW |
| IVERIC bio, Inc. | 25,980 | 51.8% |
Top Reduces (Value $000, Stocks/ETFs)
| VTRS | -125,514 | -58.0% |
| SRPT | -111,766 | -100.0% |
| GKOS | -47,215 | -100.0% |
| AHCO | -46,722 | -23.2% |
| DAWN | -42,196 | -67.1% |
| Deciphera Pharmaceuticals, Inc. | -36,107 | -43.9% |
| NBIX | -35,534 | -18.1% |
| Horizon Therapeutics Public Ltd Co | -24,965 | -100.0% |
| MOH | -21,957 | -47.0% |
| ORGO | -21,705 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
17,940
(0.4% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|